Caprock Group, Inc. Adaptive Biotechnologies Corp Transaction History

Caprock Group, Inc.

  • $3.21 Billion
  • Q1 2025

A detailed history of Caprock Group, Inc. transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Caprock Group, Inc. holds 10,944 shares of ADPT stock, worth $133,516. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,944
Previous 10,415 5.08%
Holding current value
$133,516
Previous $62,000 30.65%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
BUY
$6.07 - $8.66 $3,211 - $4,581
529 Added 5.08%
10,944 $81,000
Q4 2024

Jan 23, 2025
SELL
$4.37 - $6.78 $10,925 - $16,950
-2,500 Reduced 19.36%
10,415 $62,000
Q3 2024

Nov 07, 2024
BUY
$3.37 - $5.12 $1,203 - $1,827
357 Added 2.84%
12,915 $66,000
Q2 2024

Aug 06, 2024
SELL
$2.34 - $3.96 $29,287 - $49,563
-12,516 Reduced 49.92%
12,558 $45,000
Q1 2024

Apr 29, 2024
SELL
$2.88 - $4.8 $80 - $134
-28 Reduced 0.11%
25,074 $80,000
Q4 2023

Jan 18, 2024
SELL
$3.46 - $5.33 $58 - $90
-17 Reduced 0.07%
25,102 $122,000
Q3 2023

Oct 18, 2023
SELL
$5.07 - $8.44 $1,521 - $2,532
-300 Reduced 1.18%
25,119 $136,000
Q4 2022

Jan 23, 2023
SELL
$6.26 - $9.34 $12,012 - $17,923
-1,919 Reduced 7.02%
25,419 $0
Q3 2022

Nov 07, 2022
SELL
$6.5 - $12.67 $2,691 - $5,245
-414 Reduced 1.49%
27,338 $195,000
Q2 2022

Jul 26, 2022
SELL
$6.4 - $14.73 $29,350 - $67,551
-4,586 Reduced 14.18%
27,752 $225,000
Q1 2022

Apr 12, 2022
SELL
$10.12 - $28.9 $30,359 - $86,700
-3,000 Reduced 8.49%
32,338 $449,000
Q4 2021

Jan 18, 2022
SELL
$25.17 - $36.85 $269,319 - $394,295
-10,700 Reduced 23.24%
35,338 $992,000
Q2 2021

Aug 13, 2021
SELL
$32.22 - $44.59 $96,660 - $133,770
-3,000 Reduced 6.12%
46,038 $1.88 Million
Q1 2021

Apr 29, 2021
BUY
$37.26 - $67.74 $698,923 - $1.27 Million
18,758 Added 61.95%
49,038 $1.97 Million
Q4 2020

Jan 29, 2021
SELL
$45.01 - $65.47 $469,454 - $682,852
-10,430 Reduced 25.62%
30,280 $1.79 Million
Q3 2020

Oct 29, 2020
SELL
$35.79 - $48.81 $268,425 - $366,075
-7,500 Reduced 15.56%
40,710 $1.98 Million
Q1 2020

Apr 28, 2020
BUY
$16.96 - $34.16 $689,797 - $1.39 Million
40,672 Added 539.56%
48,210 $1.34 Million
Q4 2019

Feb 04, 2020
BUY
$24.56 - $32.8 $933 - $1,246
38 Added 0.51%
7,538 $226,000
Q3 2019

Oct 31, 2019
BUY
$30.31 - $53.51 $227,325 - $401,325
7,500 New
7,500 $232,000

Others Institutions Holding ADPT

# of Institutions
254
Shares Held
152M
Call Options Held
44.3K
Put Options Held
47.8K
View Full List

About Adaptive Biotechnologies Corp

ADPT Quotes by TradingView
  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $1.74B
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Caprock Group, Inc. Portfolio

Follow Caprock Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caprock Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Caprock Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email